Jump to content

Drilldown: Medicines

Pharmacopedia
BrowseCategoriesLog in

Choose a table:


Medicines > routes: Oral (with MAOI) & onset : Amyloid PET clearance within months; cognitive benefit over 18 months or None

Use the filters below to narrow your results.

generic:
Mimosa hostilis (1) · Phalaris arundinaceae (1)
brand:
''Mimosa tenuiflora''. Jurema preta, tepescohuite (1) · Reed canary grass (1)
classes:
Phantastica (2) · Plant Medicine (2)
mechanism:
Contains varying amounts of DMT, 5-MeO-DMT, bufotenine, and gramine depending on strain and growing conditions. (1) · Root bark contains ~1% N,N-dimethyltryptamine (DMT) and related tryptamines. Oral activity requires MAOI co-administration. (1)
uses:
'"`UNIQ--vote-00000006-QINU`"' (1) · '"`UNIQ--vote-00000008-QINU`"', '"`UNIQ--vote-00000009-QINU`"' (1)
starting dose:
None (2)
preparations:
Acid/base extraction of fresh young grass for tryptamines; combined with an MAOI (1) · Root bark acid/base-extracted for DMT; or as the resurrected ''jurema preta'' brew (decocted with an MAOI such as ''Peganum harmala'') (1)
fda max:
None (2)
routes: (Click arrow to add another value)
onset: (Click arrow to add another value)
duration:
None (2)
halflife:
None (2)
bioavailability:
None (2)
pregnancy:
None (2)
legal:
None (2)

Showing below up to 2 results in range #1 to #2.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"